Markets bounced back on Tuesday to the tune of about 1%, this came after Monday’s debacle in the tech sector. ARK Funds changed their tunes too and each had a fairly positive day. ARKF performed the best out of the group, up 2.3%, while ARKX did the worst, up 1.0% on the day. The gains from past year are slowly sliding away, but Cathie Wood may have something up her sleeve as she is constantly reshuffling her ETFs to stand up to market headwinds.
ARK Invest has been the talk of Wall Street over the past couple of years, outperforming the market and solidifying its place among the big players in the investments world. Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.
Many traders are looking to mirror the plays of famous investors and huge brokerage firms to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases a list of its trades at the end of each trading day.
While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here is a quick look at some of the major buys that ARK Invest executed on October 5, 2021. Also check out all the ARK Invest sales that took place that same day.
The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks, as the name suggests. Some of its biggest holdings include Square, Zillow, Pinterest, PayPal and Alibaba. Net assets for the fund are currently $4.0 billion. Here are some notable purchases in this fund: 33,388 shares of Toast, 151,697 shares of Robinhood, & 243,301 shares of UiPath.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries, but the general focus is on health care and companies that are changing the game technologically in this field. The biggest holdings are Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $9.7 billion. Here are some notable buys in this fund: 188,676 shares of Surface Oncology, 391,069 shares of Signify Health, & 119,754 shares of Quantum-Si.
ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation across multiple industries, but primarily tech. Some of the biggest names are in this fund, including Tesla, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $25.5 billion. Here are some notable purchases in this fund: 154,175 shares of Teladoc, 358,048 shares of Signify Health, 658,606 shares of Pacific Bio, & 188,902 shares of Ginkgo Bioworks.
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused, unsurprisingly, on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. Big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.1 billion. Here are a few buys of note in this fund: 141,418 shares of Markforged & 61,699 shares of Blade Air Mobility.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) is focused on companies that are disruptively innovating within the theme of the next generation of the internet. Some names in this fund are similar to the others, including Tesla, Square, Grayscale Bitcoin Trust, Facebook and Snap. Net assets for this fund are currently $6.4 billion. Here are a few notable purchases in this fund: 48,009 shares of Vuzix, 35,194 shares of Square, & 33,762 shares of 2U.
Ark Space Exploration & Innovation ETF (NYSEARCA: ARKX) is focused primarily on companies developing technology around spaceflight. Big names in this fund include Trimble, Kratos, Nvidia, Amazon and Iridium. Net assets for this fund are currently $63.3 million. Buys worth noting in this fund: 52,252 shares of UiPath & 19,765 shares of The 3D Printing ETF.
Check out all the buys here:
FUND | Direction | Ticker | Name | Shares |
---|---|---|---|---|
ARKF | Buy | TOST | TOAST INC | 33,388 |
ARKF | Buy | HOOD | ROBINHOOD MARKETS INC | 151,697 |
ARKF | Buy | PATH | UIPATH INC | 243,301 |
ARKG | Buy | SURF | SURFACE ONCOLOGY INC | 188,676 |
ARKG | Buy | SLGC | SOMALOGIC INC | 80,200 |
ARKG | Buy | SGFY | SIGNIFY HEALTH INC | 391,069 |
ARKG | Buy | QSI | QUANTUM-SI INC | 119,754 |
ARKG | Buy | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 124,974 |
ARKG | Buy | MASS | 908 DEVICES INC | 18,000 |
ARKG | Buy | DYNS | DYNAMICS SPECIAL PURPOSE CORP | 204 |
ARKG | Buy | ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | 105,175 |
ARKG | Buy | BEAM | BEAM THERAPEUTICS INC | 12,094 |
ARKK | Buy | TWOU | 2U INC | 132,665 |
ARKK | Buy | TDOC | TELADOC HEALTH INC | 154,175 |
ARKK | Buy | SSYS | STRATASYS LTD | 26,693 |
ARKK | Buy | SGFY | SIGNIFY HEALTH INC | 358,048 |
ARKK | Buy | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 658,606 |
ARKK | Buy | DNA | GINKGO BIOWORKS HOLDINGS INC | 188,902 |
ARKK | Buy | BEAM | BEAM THERAPEUTICS INC | 92,397 |
ARKQ | Buy | VLD | VELO3D INC | 38,569 |
ARKQ | Buy | NIU | NIU TECHNOLOGIES | 2,300 |
ARKQ | Buy | MKFG | MARKFORGED HOLDING CORP | 141,418 |
ARKQ | Buy | BLDE | BLADE AIR MOBILITY INC | 61,699 |
ARKQ | Buy | ACHR | ARCHER AVIATION INC | 80,143 |
ARKW | Buy | VUZI | VUZIX CORP | 48,009 |
ARKW | Buy | TWOU | 2U INC | 33,762 |
ARKW | Buy | SQ | SQUARE INC | 35,194 |
ARKX | Buy | BLDE | BLADE AIR MOBILITY INC | 3,733 |
ARKX | Buy | PATH | UIPATH INC | 52,252 |
ARKX | Buy | PRNT | THE 3D PRINTING ETF | 19,765 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Find a Qualified Financial Advisor (Sponsor)
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.